{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:13:54Z","timestamp":1793142834293,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371369"],"award-info":[{"award-number":["32371369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11932014"],"award-info":[{"award-number":["11932014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02836-w","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:43:20Z","timestamp":1774406600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Celecoxib inhibits COX-2 and initiates YAP-dependent mitochondrial apoptosis via YBX1 shuttling in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhe","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Z.","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2836_CR1","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"2836_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.surg.2013.02.019","volume":"154","author":"RE Beard","year":"2013","unstructured":"Beard RE, Hanto DW, Gautam S, Miksad RA. A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution. Surgery. 2013;154:545\u201355.","journal-title":"Surgery"},{"key":"2836_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245\u201355.","journal-title":"Lancet"},{"key":"2836_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835\u201353.","journal-title":"Gastroenterology"},{"key":"2836_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"2836_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"2836_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cdp.2003.12.005","volume":"28","author":"K Kismet","year":"2004","unstructured":"Kismet K, Akay MT, Abbasoglu O, Ercan A. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev. 2004;28:127\u201342.","journal-title":"Cancer Detect Prev"},{"key":"2836_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1389450119666180803121737","volume":"20","author":"N To\u0142oczko-Iwaniuk","year":"2019","unstructured":"To\u0142oczko-Iwaniuk N, Dziemia\u0144czyk-Pakie\u0142a D, Nowaszewska KB, Celi\u0144ska-Janowicz K, Miltyk W. Celecoxib in cancer therapy and prevention \u2013 review. Curr Drug Targets. 2019;20:302\u201315.","journal-title":"Curr Drug Targets"},{"key":"2836_CR9","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1002\/jcp.26586","volume":"233","author":"K Mortezaee","year":"2018","unstructured":"Mortezaee K. Human hepatocellular carcinoma: Protection by melatonin. J Cell Physiol. 2018;233:6486\u2013508.","journal-title":"J Cell Physiol"},{"key":"2836_CR10","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1002\/jcp.27411","volume":"234","author":"N Hashemi Goradel","year":"2019","unstructured":"Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: a review. J Cell Physiol. 2019;234:5683\u201399.","journal-title":"J Cell Physiol"},{"key":"2836_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.seminoncol.2004.03.042","volume":"31","author":"B Arun","year":"2004","unstructured":"Arun B, Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol. 2004;31:22\u20139.","journal-title":"Semin Oncol"},{"key":"2836_CR12","doi-asserted-by":"publisher","first-page":"106379","DOI":"10.1016\/j.prostaglandins.2019.106379","volume":"147","author":"P Saxena","year":"2020","unstructured":"Saxena P, Sharma PK, Purohit P. A journey of celecoxib from pain to cancer. Prostaglandins Other Lipid Mediat. 2020;147:106379.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2836_CR13","doi-asserted-by":"publisher","first-page":"8622","DOI":"10.1093\/nar\/gks579","volume":"40","author":"WJ Wei","year":"2012","unstructured":"Wei WJ, Mu SR, Heiner M, Fu X, Cao LJ, Gong XF, Bindereif A, Hui J. YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts. Nucleic Acids Res. 2012;40:8622\u201336.","journal-title":"Nucleic Acids Res"},{"key":"2836_CR14","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/sj.onc.1208504","volume":"24","author":"IM Berquin","year":"2005","unstructured":"Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 2005;24:3177\u201386.","journal-title":"Oncogene"},{"key":"2836_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-020-2968-3","volume":"588","author":"AK Jayavelu","year":"2020","unstructured":"Jayavelu AK, Schnoder TM, Perner F, Herzog C, Meiler A, Krishnamoorthy G, Huber N, Mohr J, Edelmann-Stephan B, Austin R, et al. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature. 2020;588:157\u201363.","journal-title":"Nature"},{"key":"2836_CR16","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.3748\/wjg.v27.i28.4667","volume":"27","author":"T Liu","year":"2021","unstructured":"Liu T, Xie XL, Zhou X, Chen SX, Wang YJ, Shi LP, Chen SJ, Wang YJ, Wang SL, Zhang JN, et al. Y-box binding protein 1 augments sorafenib resistance via the PI3K\/Akt signaling pathway in hepatocellular carcinoma. World J Gastroenterol. 2021;27:4667\u201386.","journal-title":"World J Gastroenterol"},{"key":"2836_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI88486","volume":"127","author":"W Kim","year":"2017","unstructured":"Kim W, Khan SK, Gvozdenovic-Jeremic J, Kim Y, Dahlman J, Kim H, Park O, Ishitani T, Jho EH, Gao B, Yang Y. Hippo signaling interactions with Wnt\/beta-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137\u201352.","journal-title":"J Clin Invest"},{"key":"2836_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","volume":"128","author":"SH Jeong","year":"2018","unstructured":"Jeong SH, Kim HB, Kim MC, Lee JM, Lee JH, Kim JH, Kim JW, Park WY, Kim SY, Kim JB, et al. Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer. J Clin Invest. 2018;128:1010\u201325.","journal-title":"J Clin Invest"},{"key":"2836_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, Rosato A, Bicciato S, Cordenonsi M, Piccolo S. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17:1218.","journal-title":"Nat Cell Biol"},{"key":"2836_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-018-0158-8","volume":"24","author":"F Zanconato","year":"2018","unstructured":"Zanconato F, Battilana G, Forcato M, Filippi L, Azzolin L, Manfrin A, Quaranta E, Di Biagio D, Sigismondo G, Guzzardo V, et al. Transcriptional addiction in cancer cells is mediated by YAP\/TAZ through BRD4. Nat Med. 2018;24:1599\u2013610.","journal-title":"Nat Med"},{"key":"2836_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73\u20139.","journal-title":"Nat Rev Cancer"},{"key":"2836_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","volume":"5","author":"CDK Nguyen","year":"2019","unstructured":"Nguyen CDK, Yi C. YAP\/TAZ Signaling and Resistance to Cancer Therapy. Trends Cancer. 2019;5:283\u201396.","journal-title":"Trends Cancer"},{"key":"2836_CR23","doi-asserted-by":"publisher","first-page":"119211","DOI":"10.1016\/j.bbamcr.2022.119211","volume":"1869","author":"H Yu","year":"2022","unstructured":"Yu H, Hou Z, Xiang M, Yang F, Ma J, Yang L, Ma X, Zhou L, He F, Miao M, et al. Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells. Biochim Biophys Acta Mol Cell Res. 2022;1869:119211.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2836_CR24","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1002\/1878-0261.13061","volume":"15","author":"H Yu","year":"2021","unstructured":"Yu H, He J, Su G, Wang Y, Fang F, Yang W, Gu K, Fu N, Wang Y, Shen Y, Liu X. Fluid shear stress activates YAP to promote epithelial\u2013mesenchymal transition in hepatocellular carcinoma. Mol Oncol. 2021;15:3164\u201383.","journal-title":"Mol Oncol"},{"key":"2836_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.019","volume":"367","author":"J Chen","year":"2015","unstructured":"Chen J, Jin R, Zhao J, Liu J, Ying H, Yan H, Zhou S, Liang Y, Huang D, Liang X, et al. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Lett. 2015;367:1\u201311.","journal-title":"Cancer Lett"},{"key":"2836_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2836_CR27","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","volume":"66","author":"MA Kern","year":"2006","unstructured":"Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, et al. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res. 2006;66:7059\u201366.","journal-title":"Cancer Res"},{"key":"2836_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1053\/jhep.2002.36125","volume":"36","author":"MA Kern","year":"2002","unstructured":"Kern MA, Schubert D, Sahi D, Schoneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology. 2002;36:885\u201394.","journal-title":"Hepatology"},{"key":"2836_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yexcr.2005.01.011","volume":"306","author":"JY Liou","year":"2005","unstructured":"Liou JY, Aleksic N, Chen SF, Han TJ, Shyue SK, Wu KK. Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res. 2005;306:75\u201384.","journal-title":"Exp Cell Res"},{"key":"2836_CR30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.7150\/thno.17647","volume":"7","author":"TJ Zhou","year":"2017","unstructured":"Zhou TJ, Zhang SL, He CY, Zhuang QY, Han PY, Jiang SW, Yao H, Huang YJ, Ling WH, Lin YC, Lin ZN. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1. Theranostics. 2017;7:1389\u2013406.","journal-title":"Theranostics"},{"key":"2836_CR31","first-page":"1410","volume":"7","author":"SH Bae","year":"2001","unstructured":"Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res. 2001;7:1410\u20138.","journal-title":"Clin Cancer Res"},{"key":"2836_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","volume":"70","author":"Y Chen","year":"2019","unstructured":"Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J, Zhang Z, Luo M, Lei Y, Peng Y, et al. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 2019;70:66\u201377.","journal-title":"J Hepatol"},{"key":"2836_CR33","doi-asserted-by":"publisher","first-page":"D33","DOI":"10.1093\/nar\/gky822","volume":"47","author":"H Hu","year":"2019","unstructured":"Hu H, Miao YR, Jia LH, Yu QY, Zhang Q, Guo AY. AnimalTFDB 3.0: a comprehensive resource for annotation and prediction of animal transcription factors. Nucleic Acids Res. 2019;47:D33\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2836_CR34","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1038\/onc.2015.491","volume":"35","author":"A Dey","year":"2016","unstructured":"Dey A, Robitaille M, Remke M, Maier C, Malhotra A, Gregorieff A, Wrana JL, Taylor MD, Angers S, Kenney AM. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells. Oncogene. 2016;35:4256\u201368.","journal-title":"Oncogene"},{"key":"2836_CR35","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cell.2016.11.005","volume":"167","author":"T Moroishi","year":"2016","unstructured":"Moroishi T, Hayashi T, Pan WW, Fujita Y, Holt MV, Qin J, Carson DA, Guan KL. The Hippo Pathway Kinases LATS1\/2 Suppress Cancer Immunity. Cell. 2016;167:1525\u2013e15391517.","journal-title":"Cell"},{"key":"2836_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"Lee CK, Jeong SH, Jang C, Bae H, Kim YH, Park I, Kim SK, Koh GY. Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science. 2019;363:644\u20139.","journal-title":"Science"},{"key":"2836_CR37","first-page":"27","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang C, Zhu X, Feng W, Yu Y, Mills GB. Verteporfin inhibits YAP function through up-regulating 14-3-3\u03c3 sequestering YAP in the cytoplasm. Am J Cancer Res. 2015;6:27\u201337.","journal-title":"Am J Cancer Res"},{"key":"2836_CR38","doi-asserted-by":"publisher","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","volume":"271","author":"WL Smith","year":"1996","unstructured":"Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and \u2013\u20092. J Biol Chem. 1996;271:33157\u201360.","journal-title":"J Biol Chem"},{"key":"2836_CR39","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1021\/acs.analchem.7b05337","volume":"90","author":"B Gurram","year":"2018","unstructured":"Gurram B, Zhang S, Li M, Li H, Xie Y, Cui H, Du J, Fan J, Wang J, Peng X. Celecoxib Conjugated Fluorescent Probe for Identification and Discrimination of Cyclooxygenase-2 Enzyme in Cancer Cells. Anal Chem. 2018;90:5187\u201393.","journal-title":"Anal Chem"},{"key":"2836_CR40","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.18632\/oncotarget.23865","volume":"9","author":"B Hoing","year":"2018","unstructured":"Hoing B, Kanaan O, Altenhoff P, Petri R, Thangavelu K, Schluter A, Lang S, Bankfalvi A, Brandau S. Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma. Oncotarget. 2018;9:8415\u201326.","journal-title":"Oncotarget"},{"key":"2836_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/bjc.2011.204","volume":"105","author":"JA Glover","year":"2011","unstructured":"Glover JA, Hughes CM, Cantwell MM, Murray LJ. A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer. Br J Cancer. 2011;105:13\u20137.","journal-title":"Br J Cancer"},{"key":"2836_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, et al. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE(2)-Mediated Suppression of Antitumor Immunity. Cancer Discov. 2017;7:522\u201338.","journal-title":"Cancer Discov"},{"key":"2836_CR43","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/onc.2017.73","volume":"36","author":"H Chen","year":"2017","unstructured":"Chen H, Cai W, Chu ESH, Tang J, Wong CC, Wong SH, Sun W, Liang Q, Fang J, Sun Z, Yu J. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice. Oncogene. 2017;36:4415\u201326.","journal-title":"Oncogene"},{"key":"2836_CR44","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1038\/onc.2008.322","volume":"27","author":"Y Liu","year":"2008","unstructured":"Liu Y, Borchert GL, Surazynski A, Phang JM. Proline oxidase, a p53-induced gene, targets COX-2\/PGE signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene. 2008;27:6729\u201337.","journal-title":"Oncogene"},{"key":"2836_CR45","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/sj.onc.1210084","volume":"26","author":"Y Basaki","year":"2007","unstructured":"Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Sakai K, et al. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene. 2007;26:2736\u201346.","journal-title":"Oncogene"},{"key":"2836_CR46","doi-asserted-by":"crossref","unstructured":"Hartley AV, Wang BL, Mundade R, Jiang GL, Sun MY, Wei H, Sun S, Liu YL, Lu T. PRMT5-mediated methylation of YBX1 regulates NF-\u03baB activity in colorectal cancer. Sci Rep. 2020;10:15934.","DOI":"10.1038\/s41598-020-72942-3"},{"key":"2836_CR47","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/sj.onc.1208590","volume":"24","author":"BW Sutherland","year":"2005","unstructured":"Sutherland BW, Kucab J, Wu J, Lee C, Cheang MCU, Yorida E, Turbin D, Dedhar S, Nelson C, Pollak M, et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene. 2005;24:4281\u201392.","journal-title":"Oncogene"},{"key":"2836_CR48","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.7150\/ijbs.69514","volume":"18","author":"P Liu","year":"2022","unstructured":"Liu P, Zhong Q, Song Y, Guo D, Ma D, Chen B, Lan J, Liu Q. Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494\/ATF3\/p53 axis and promoting ubiquitination of YBX1. Int J Biol Sci. 2022;18:2932\u201348.","journal-title":"Int J Biol Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02836-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02836-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02836-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:02:57Z","timestamp":1777892577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02836-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2836"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02836-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study procedures followed the Declaration of Helsinki and the International Council for Harmonisation Good Clinical Practice guidelines and all local regulatory requirements. All patients provided informed consent before participating in any study-related procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}